| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/30/2023 | BioAtla, Inc. | | Grant | Common Stock | 8.7k | $0.00 | $0 | | 09/30/2023 |
| 06/30/2023 | BioAtla, Inc. | | Grant | Common Stock | 4.9k | $0.00 | $0 | | 06/30/2023 |
| 06/14/2023 | BioAtla, Inc. | | Grant | Stock Option (Right to Buy) | 50k | $3.55 | $177.5k | | 06/14/2023 |
| 06/06/2023 | Keros Therapeutics, Inc. | KROS | Grant | Stock Option (right to buy) | 10k | $48.79 | $487.9k | | 06/06/2023 |
| 05/24/2023 | RAPT Therapeutics, Inc. | RAPT | Grant | Stock Option (right to buy) | 12.9k | $20.93 | $270.8k | | 05/24/2023 |
| 03/31/2023 | BioAtla, Inc. | | Grant | Common Stock | 5.5k | $0.00 | $0 | | 03/31/2023 |
| 02/08/2023 | Compass Therapeutics, Inc. | CMPX | Grant | Stock Option (Right to Buy) | 40k | $3.93 | $157.2k | | 02/08/2023 |
| 06/16/2022 | BioAtla, Inc. | | Grant | Stock Option (right to buy) | 20k | $2.48 | $49.6k | | 06/16/2022 |
| 06/01/2022 | Keros Therapeutics, Inc. | KROS | Grant | Stock Options (right to buy) | 8.3k | $32.95 | $273.3k | | 06/01/2022 |
| 05/25/2022 | RAPT Therapeutics, Inc. | RAPT | Grant | Stock Option (right to buy) | 8.5k | $13.64 | $115.9k | | 05/25/2022 |
| 04/26/2022 | Compass Therapeutics, Inc. | CMPX | Grant | Stock Option (Right to Buy) | 45k | $1.51 | $68k | | 04/26/2022 |
| 03/31/2022 | RAPT Therapeutics, Inc. | RAPT | Grant | Stock Option (right to buy) | 3.9k | $21.99 | $85.1k | | 03/31/2022 |
| 03/07/2022 | Sarepta Therapeutics, Inc. | SRPT | Grant | Common Stock | 3k | $0.00 | $0 | | 03/07/2022 |
| 03/07/2022 | Sarepta Therapeutics, Inc. | SRPT | Grant | Stock Option (right to buy) | 5.1k | $80.42 | $408.3k | | 03/07/2022 |
| 12/10/2021 | Sarepta Therapeutics, Inc. | SRPT | Exercise | Restricted Stock Units | 967 | $0.00 | $0 | | 12/10/2021 |
| 11/18/2021 | PALISADE BIO, INC. | CUR | Grant | Stock Option (right to buy) | 48.3k | $2.32 | $112.1k | | 11/18/2021 |
| 06/15/2021 | BioAtla, Inc. | | Grant | Stock Option (right to buy) | 12.3k | $39.64 | $487.8k | | 06/15/2021 |
| 06/01/2021 | Keros Therapeutics, Inc. | KROS | Grant | Stock Option (right to buy) | 8.3k | $51.48 | $426.9k | | 06/01/2021 |
| 05/28/2021 | RAPT Therapeutics, Inc. | RAPT | Grant | Stock Option (right to buy) | 7.5k | $19.30 | $144.8k | | 05/28/2021 |
| 04/01/2021 | PALISADE BIO, INC. | CUR | Grant | | 6k | $0.00 | $0 | | 04/01/2021 |
| 03/31/2021 | RAPT Therapeutics, Inc. | RAPT | Grant | Stock Option (right to buy) | 3.8k | $22.20 | $84.8k | | 03/31/2021 |
| 03/03/2021 | Sarepta Therapeutics, Inc. | SRPT | Grant | Common Stock | 2.7k | $0.00 | $0 | | 03/03/2021 |
| 03/03/2021 | Sarepta Therapeutics, Inc. | SRPT | Grant | Stock Option (right to buy) | 5.5k | $87.11 | $480.7k | | 03/03/2021 |
| 12/17/2020 | Keros Therapeutics, Inc. | KROS | Grant | Stock Option (right to buy) | 16.6k | $82.74 | $1.4M | | 12/17/2020 |
| 12/10/2020 | Sarepta Therapeutics, Inc. | SRPT | Exercise | Restricted Stock Units | 967 | $0.00 | $0 | | 12/10/2020 |
| 06/18/2020 | RAPT Therapeutics, Inc. | RAPT | Grant | Stock Option (right to buy) | 7.5k | $28.27 | $212k | | 06/18/2020 |
| 04/03/2020 | PALISADE BIO, INC. | CUR | Grant | | 6k | $0.00 | $0 | | 04/03/2020 |
| 03/31/2020 | RAPT Therapeutics, Inc. | RAPT | Grant | Stock Option (right to buy) | 4k | $21.27 | $84.7k | | 03/31/2020 |
| 02/28/2020 | Sarepta Therapeutics, Inc. | SRPT | Grant | Common Stock | 2.1k | $0.00 | $0 | | 02/28/2020 |
| 02/28/2020 | Sarepta Therapeutics, Inc. | SRPT | Grant | Stock option (right to buy) | 3.7k | $114.47 | $421.8k | | 02/28/2020 |
| 12/10/2019 | Sarepta Therapeutics, Inc. | SRPT | Exercise | Restricted Stock Units | 967 | $0.00 | $0 | | 12/10/2019 |
| 12/04/2019 | RAPT Therapeutics, Inc. | RAPT | Grant | Stock Option (right to buy) | 22.5k | $27.53 | $619.4k | | 12/04/2019 |
| 03/04/2019 | Sarepta Therapeutics, Inc. | SRPT | Grant | Common Stock | 1.6k | $0.00 | $0 | | 03/04/2019 |
| 03/04/2019 | Sarepta Therapeutics, Inc. | SRPT | Grant | Stock option (right to buy) | 3.2k | $145.48 | $467.4k | | 03/04/2019 |
| 12/10/2018 | Sarepta Therapeutics, Inc. | SRPT | Grant | Option (right to buy) | 5.7k | $122.80 | $701.3k | | 12/10/2018 |
|